- Home
- Products
Cablivi (Caplacizumab-yhdp)
Cablivi (Caplacizumab-yhdp)
- Medicine Name: Cablivi
- Generic Name: Caplacizumab-yhdp
- Dosage Form & Strength: 11 mg lyophilized powder in a single-dose vial for injection
- Manufactured By: Ablynx
Cablivi is a von Willebrand factor (vWF)-targeting antibody fragment prescribed for adult patients diagnosed with acquired thrombotic thrombocytopenic purpura (aTTP). It is administered alongside immunosuppressive therapy and plasma exchange to help prevent the formation of microvascular blood clots.
Recommended Dosage:
- Day 1: 11 mg intravenous bolus injection at least 15 minutes before plasma exchange, followed by 11 mg subcutaneous injection after plasma exchange
- During plasma exchange: 11 mg subcutaneous injection once daily after each session
- Post-plasma exchange: Continue with 11 mg subcutaneous injection once daily for 30 days following the last plasma exchange
- Extended therapy: May be extended by at least 28 additional days in patients with persistent signs of aTTP
Treatment should be discontinued if a patient experiences more than two recurrences of aTTP during therapy.
Bleeding Risk: Cablivi may increase the risk of severe bleeding. Suspend treatment if clinically significant bleeding occurs. Avoid using the drug within 7 days before elective surgical or dental procedures.
Hypersensitivity: Not recommended for individuals with known hypersensitivity to caplacizumab or its excipients. Reactions may include urticaria.
Pregnancy: The medicine may raise the risk of bleeding complications in both mother and fetus. Use during pregnancy should be guided by a healthcare provider.
Required Documents to Import Cablivi into India:
- Valid prescription from a certified medical practitioner
- Diagnostic test reports indicating the need for treatment
- Government-issued patient ID proof
Availability in India:
Cablivi is a prescription-only medicine and can be legally imported into India under the Named Patient Program for personal use by patients or authorized hospitals.
Global Rare Meds Offers:
- Assistance with procurement through legally authorized suppliers in the USA, Canada, Europe, and Australia
- Secure delivery to cities like Mumbai, Delhi, Bengaluru, Hyderabad, Chennai, Kolkata, Ahmedabad, Pune, and others
- Transparent process and compliance with all import guidelines
Orders are confirmed upon receipt of the required prescription and import documentation (if applicable).
Contact us for support:
📧 info@globalraremeds.com
📞 +91-99675 15602 (Call/WhatsApp)
Global Rare Meds sources Cablivi from internationally authorized distributors and ensures delivery through legally compliant channels. All orders are processed from our licensed fulfillment center in Ambernath, Thane District, India.
Medications are shipped directly to the patient’s address after verification by registered pharmacists, with full attention to product integrity, temperature control, and documentation.
Q: What is the generic name of Cablivi®?
A: Caplacizumab-yhdp
Q: Who manufactures Cablivi®?
A: Ablynx
Q: Is Cablivi® approved by the FDA?
A: Yes, Cablivi was approved by the U.S. FDA on February 6, 2019.
Q: What is the formulation and strength of Cablivi®?
A: Cablivi is supplied as a lyophilized powder for injection (11 mg single-dose vial).
Q: What are common side effects?
A: Common adverse effects include headache, nasal bleeding, and gum bleeding.
Q: How should Cablivi® be stored?
A: Store refrigerated between 2°C to 8°C (36°F to 46°F) in the original packaging, protected from light. The unopened vial may be stored at room temperature (up to 30°C) for a one-time period of up to two months.
Q: What is the price of Cablivi® in India?
A: Pricing varies based on availability and sourcing location. Contact info@globalraremeds.com or call/WhatsApp +91-99675 15602 for latest details.
Q: Is it legal to buy Cablivi® online in India?
A: Yes, through Global Rare Meds, patients can legally procure Cablivi under proper medical guidance and applicable regulatory compliance.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
